Outbreak of adverse reactions associated with contaminated heparin - Wikidata - awgldk - TriplyDB

Outbreak of adverse reactions associated with contaminated heparin

Outbreak of adverse reactions associated with contaminated heparin

http://www.wikidata.org/entity/Q34893200

about

Pentasaccharides for the treatment of deep vein thrombosis Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients Analysis and characterization of heparin impurities Fucanomics and galactanomics: marine distribution, medicinal impact, conceptions, and challenges Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.Contaminated heparin-affected patient plasmas are associated with activated contact systems.Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Contaminated heparin and outcomes after cardiac surgery: a retrospective propensity-matched cohort study.Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions.Quality assurance of medicines supplied to low-income and middle-income countries: poor products in shiny boxes?Characterization of glycosaminoglycans by 15N NMR spectroscopy and in vivo isotopic labeling.Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways Identification of Chemically Sulfated/desulfated Glycosaminoglycans in Contaminated Heparins and Development of a Simple Assay for the Detection of Most Contaminants in Heparin.Substandard drugs: a potential crisis for public health.Does the heparin lock concentration affect hemodialysis catheter patency?Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse events Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity.A personal account of translating discoveries in an academic lab.Ongoing challenges in pharmacovigilance.Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitor.Selective light-triggered release of DNA from gold nanorods switches blood clotting on and off.Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.Applications of isotopes in advancing structural and functional heparanomics.Mass balance analysis of contaminated heparin product.Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model.Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.Poly(vinyl sulfonate) Facilitates bFGF-Induced Cell Proliferation.The design and synthesis of new synthetic low-molecular-weight heparins.Orthogonal analytical approaches to detect potential contaminants in heparin

P2860

Q24186811-B94AEE00-723E-40D1-B0D5-55B2E09CA5F5 Q24200589-89A72E8A-C197-4B1E-912F-53EF8E8AEC5E Q24605666-36F50235-FFD3-4124-87A7-DE6895C24CFA Q26830100-17C986CC-B537-4D41-84E0-3863ED4D255F Q27002491-C3FFEF63-32AA-4A8C-92DB-6D56AE4A1F13 Q28474000-51C4347F-9CFA-43B1-9634-4510DD500AB7 Q30661960-7A492429-D1E1-4D46-A7EE-8B46813A6508 Q33389514-8924EB9F-6673-4621-BF4A-16BC950910E5 Q33390123-011D48E5-44E5-4784-830E-1B566F5AE1B7 Q33393960-A3BAB9E0-6B69-4027-8353-F8AEA22C22A5 Q33399576-F0D195EC-AFF2-4C98-B121-D0C547029F46 Q33417350-DE6E8033-2F43-4829-A3E9-6F77747FF542 Q33441234-03730945-50EA-436D-970C-76AFC25A5726 Q33460885-3E1C55AD-E08F-478B-9F67-045A2C5626D7 Q33470885-F26B9889-DF22-4451-8E64-C0495F560DA9 Q33630627-E9BEE162-992B-46D9-81D4-07F52E2D0E06 Q33699168-0C3DBE50-BBFA-43F1-A327-2B15435DB779 Q33909062-762F6C0D-DA8D-4E23-AD42-5A4A89CCCC12 Q33957321-17BE3F33-4E19-4F48-911D-8167F2C4B7CB Q33975255-6DC602B1-9263-491C-AB69-F22A5D7D9C27 Q34003880-CB22FE8E-9011-4F51-89F2-933AE5D77510 Q34016400-1B0860C0-2503-491F-8E21-326B35D1EB12 Q34065256-BF6D90C7-FD14-427D-A8C4-2A179D59B7F9 Q34075453-FB34E812-634C-4EF7-B0A6-EC45D41C3F8D Q34238816-68FF725E-50D0-4CCD-9A3A-120CCF324447 Q34317336-4A8E624B-D5C0-4648-A3E0-1809E8FFC744 Q34349829-A54D972D-AD20-461E-B8D8-2389CBF9E5A9 Q34417013-ACBCA0FF-420F-4D1E-81AF-2921319AA20F Q34450711-6F5E23D4-B6A1-484F-A71A-C0F2EE46CB6A Q34872748-EC9B9327-6323-40A3-A917-3D1C7B4D1257 Q35001659-3EF0CE27-BFC8-42F1-B7E7-4D2057AB8BC6 Q35083201-EC5B337F-2C60-4F7E-9BA4-66898B3888C2 Q35234372-44D6CB70-F20A-4E50-B15E-6E85E6D85378 Q36131630-BC040B00-4147-4526-B3CA-8372E49DD0BC Q36270533-29FC2491-A92A-40BD-B735-B8FB43B1EF02 Q36278431-7524D65F-88BF-4BC0-95EA-8A1023B03D45 Q36342914-2B0468EF-9DCE-4105-9244-DBE69086415D Q36398842-0F9F676C-EA3A-4592-9A32-1C8E011103E3 Q37004231-E16F4327-B930-4B53-83AE-7C57FC5B5C98 Q37359606-BF177717-29D6-45C1-A65E-CA8A92531DD2

P2860

Outbreak of adverse reactions associated with contaminated heparin

http://www.wikidata.org/entity/Q34893200

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Outbreak of adverse reactions associated with contaminated heparin

@ast

Outbreak of adverse reactions associated with contaminated heparin

@en

Outbreak of adverse reactions associated with contaminated heparin

@nl

type

label

Outbreak of adverse reactions associated with contaminated heparin

@ast

Outbreak of adverse reactions associated with contaminated heparin

@en

Outbreak of adverse reactions associated with contaminated heparin

@nl

prefLabel

Outbreak of adverse reactions associated with contaminated heparin

@ast

Outbreak of adverse reactions associated with contaminated heparin

@en

Outbreak of adverse reactions associated with contaminated heparin

@nl

P1433

Q34893200-791E7EA9-7C55-41BB-A0BC-0F04A22191E1

P1476

Q34893200-FC5AB412-EE2E-410A-AF91-6DDC9A37BBB4

P2093

Q34893200-26CD99E3-0454-40A5-8C83-CEFA3FB11420

Q34893200-2935FAEE-ACC7-421E-A01D-FE4FA8CAFC28

Q34893200-3A90F008-B2F6-4AEF-94A2-2325FE391DDC

Q34893200-40812621-6772-4AF8-B706-8E07F6073436

Q34893200-5929FBE9-BED3-4B4F-A5D6-93100ADF6B87

Q34893200-5D9EAAE0-D395-4878-A388-C544E214C5F2

Q34893200-697A80C6-8F4A-4D4E-976B-F17B5C62594D

Q34893200-76884874-AE69-48BA-B065-28258D610E23

Q34893200-7F3AE8F0-A653-4FEC-938F-F0776B682B77

Q34893200-8FD1D78C-744C-4E99-8A59-B83205EF1FC7

P2860

Q34893200-16E1D9EF-26F4-4BC8-915D-926186299772

Q34893200-29D04ACE-B7EB-4606-A6A5-58E9AFB26903

Q34893200-391DF970-E5A8-4FFD-BBBD-D1221EFD1166

Q34893200-4F56E957-9DC1-4BAB-964B-95868D99ACDE

Q34893200-6088C729-E0FF-495B-B653-4D2462E44D11

Q34893200-6AFA3B5A-B497-4026-8CA0-3131B13CDDEE

Q34893200-8A3C01B9-23B4-4CFE-8AE1-EC5154C775A5

Q34893200-8D9B410C-3D71-42DA-89B7-C972A9643A16

Q34893200-9A7C3751-D820-48DB-ACC7-7DFD03279F96

Q34893200-A6843D72-8ADE-4699-962D-4DA14D63419F

P304

Q34893200-718F4632-5FA7-4C5D-8C57-DA0BAD2C5B9A

P31

Q34893200-8697C035-3198-431C-B0AA-A8A9402E428F

P356

Q34893200-6C20B120-22D7-4040-BDAB-E373C7E85D48

P407

Q34893200-A3126E86-C77B-4766-A5CA-FE21EDB4A825

P433

Q34893200-A9726B0E-E3F2-41E0-AC3A-6B752E478F69

P478

Q34893200-C604148D-D889-4D62-BB6E-C0D49A73BE12

P50

Q34893200-28299360-77C6-4FC9-A8E0-6DF6F56A183C

Q34893200-8516D5CD-3822-4228-AECA-2AD8BC791AC3

P577

Q34893200-8906188E-2957-41C7-BF14-CDF28204E985

P698

Q34893200-094A5515-5889-462F-92BF-D0DBFB301D5C

P932

Q34893200-65093077-4DDE-4343-9591-B03822CB7729

P356

P1433

The New England Journal of Medicine

P1476

Outbreak of adverse reactions associated with contaminated heparin

@en

P2093

Alexander J Kallen

http://www.w3.org/2001/XMLSchema#string

Alexis Elward

http://www.w3.org/2001/XMLSchema#string

Ann W McMahon

http://www.w3.org/2001/XMLSchema#string

Arjun Srinivasan

http://www.w3.org/2001/XMLSchema#string

Carolyn V Gould

http://www.w3.org/2001/XMLSchema#string

Daniel Ketterer

http://www.w3.org/2001/XMLSchema#string

David B Blossom

http://www.w3.org/2001/XMLSchema#string

Ganesh Venkataraman

http://www.w3.org/2001/XMLSchema#string

Ganpan Gao

http://www.w3.org/2001/XMLSchema#string

George Turabelidze

http://www.w3.org/2001/XMLSchema#string

P2860

Contaminated heparin associated with adverse clinical events and activation of the contact system

Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options.

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.

Haemodialysis-associated anaphylactic and anaphylactoid reactions.

Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities.

New strategies to control the inflammatory response in cardiac surgery.

Hospital-acquired infections related to contaminated substances.

Salvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution.

Heparin-induced recurrent anaphylaxis.

Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors.

P304

2674-2684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0806450

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

359

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J Arduino

P577

2008-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19052120

http://www.w3.org/2001/XMLSchema#string

P932

3810025

http://www.w3.org/2001/XMLSchema#string